Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00011709
DRKS00011709
Recruiting
Not Applicable

Quality Assurance of Invasive Measures for Treatment of Parkinson Patients in Clinical Routine in Germany - QualiPa – THS

Institut für Klinische Epidemiologie und Biometrie (IKE-B) Universität Würzburg0 sites1,600 target enrollmentJuly 27, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOPS 5-014.9OPS 5-028.9G20Parkinson disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
OPS 5-014.9OPS 5-028.9
Sponsor
Institut für Klinische Epidemiologie und Biometrie (IKE-B) Universität Würzburg
Enrollment
1600
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2017
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Klinische Epidemiologie und Biometrie (IKE-B) Universität Würzburg

Eligibility Criteria

Inclusion Criteria

  • •Idiopathic Parkinson's syndrome (ICD\-10 code: G20\.\-),
  • •THS intervention: Stereotactic initial implantation of intracerebral microelectrodes (OPS: 5\-014\.9\-) and neurostimulators (OPS: 5\-028\.9\-)

Exclusion Criteria

  • •age \< 18 yaers, no idopatic Parkinsonsyndrom, preexisting deep brain stimulation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Quality assurance initiative for the treatment of breast cancer in Germany 2024C50Malignant neoplasm of breast
DRKS00034286KEM Evangelische Kliniken Essen Mitte3,000
Completed
Not Applicable
Quality Assurance Initiative on the Therapy of Bladder Cancer 2023C67Malignant neoplasm of bladder
DRKS00032582Arbeitsgemeinschaft Urologische Onkologie1,639
Not yet recruiting
Not Applicable
Quality assurance initiative for systemic treatment in metastatic colorectal cancerC18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectum
DRKS00033377Charite Berlin - Medizinischen Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (CCM)2,100
Recruiting
Phase 1
Corneal injury treatment protocol using 50% Autologous Serum Eye Drops
RBR-34d3jv2niversidade Federal de São Paulo - UNIFESP/EPM
Recruiting
Phase 2
A clinical study to evaluate confirmity to treatment, illness result, and quality-of-life in patients with advanced brain tumor (glioma) treated with uninterrupted short-course hypofractionated radiation therapyHealth Condition 1: null- High grade Glioma
CTRI/2012/11/003141Tata Memorial Centre Tata Memorial Hospital55